News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024
News Daily News Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome Caitlin E. Cox October 04, 2024
News Daily News Tirzepatide Provides Sustained BP Reduction in Overweight Adults Todd Neale August 15, 2024
News Conference News SCCT 2024 Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients Todd Neale July 22, 2024
News Daily News No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data Yael L. Maxwell July 15, 2024
News Daily News ‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD Todd Neale June 27, 2024
News Daily News Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years Yael L. Maxwell June 26, 2024
News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Daily News How Mediterranean Diets Might Cut Mortality in Women: New Insights Yael L. Maxwell June 05, 2024
News Daily News Time-Restricted Eating, High-Intensity Training Have Heart Benefits for Obese Women Todd Neale May 07, 2024
News Conference News ACC 2024 BE ACTIVE: Gaming for Points and Money Can Boost Step Counts L.A. McKeown April 11, 2024
News Conference News ACC 2024 Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock Caitlin E. Cox April 07, 2024
News Conference News ACC 2024 STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed L.A. McKeown April 06, 2024
News Daily News BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes Todd Neale February 02, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News Top General Cardiology and CVD Prevention News of 2023 Yael L. Maxwell January 03, 2024
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023